Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Buy
10
+7
+233% +$58 ﹤0.01% 2705
2025
Q4
$0 Hold
3
﹤0.01% 2675
2025
Q3
$0 Hold
3
﹤0.01% 2700
2025
Q2
$0 Sell
3
-68
-96% -$1.02K ﹤0.01% 2676
2025
Q1
$2K Buy
71
+17
+31% +$505 ﹤0.01% 1880
2024
Q4
$2K Buy
54
+33
+157% +$1.49K ﹤0.01% 1936
2024
Q3
$1K Buy
21
+5
+31% +$256 ﹤0.01% 2088
2024
Q2
$1K Buy
16
+4
+33% +$229 ﹤0.01% 2110
2024
Q1
$1K Buy
12
+9
+300% +$442 ﹤0.01% 2093
2023
Q4
$0 Sell
3
-1
-25% -$29 ﹤0.01% 2634
2023
Q3
$0 Buy
+4
New +$119 ﹤0.01% 2624

Other funds holding RXST

Covestor's RXST Position: Q1 2026 in Review

Covestor increased its RxSight (RXST) stake by 233% in Q1 2026, buying an estimated $58 and bringing the position to 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2705.

Covestor first reported a position in RXST in Q3 2023 and has held it in 11 quarters since. The position peaked at $2K in Q1 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Covestor held 10 shares of RxSight worth $0 as of Q1 2026.
  • Covestor bought 7 RxSight shares in Q1 2026, an estimated $58.
  • RxSight made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2705 holding.
  • Covestor first reported a position in RxSight in Q3 2023 and has held it in 11 quarters since.
  • Covestor's RxSight position peaked at $2K in Q1 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.